Using a MoCA Score to Predict the Probability of Medical Decision-Making Capacity in Patients with Mild Cognitive Impairment (MCI) or Dementia (1844)
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To assess whether the MMSE and/or MoCA could be employed as screening tools to gauge medical decision-making capacity in patients with dementia
Background: Although cognition is routinely assessed at clinical visits using screening tools such as the Montreal Cognitive Assessment (MoCA) and Mini Mental State Exam (MMSE), a patient’s capacity to make their own medical decisions is not, and the available capacity assessment tools can be time consuming to use in practice. Employing the MoCA or MMSE as a concurrent screen for capacity could allow clinicians to better anticipate and direct goals of care conversations with patients and families.
Design/Methods: 127 patients with MCI or dementia were recruited from the University of Chicago Memory Center. The MMSE, MoCA, and a formal medical decision-making capacity assessment tool were administered to all patients. Univariate and multivariable logistic regression models were fit for MMSE, MoCA, age, and gender as predictors of capacity. ROC curves were generated to assess sensitivity and specificity. Cross-validation was performed to estimate the area under the ROC curve (AUC).
Results: The mean (±SD) MoCA score for the cohort was 16±7. The mean MMSE score was 20±7. Approximately 40% (51/127) of patients were determined to have capacity using the formal capacity tool. The best model to predict capacity incorporated the MoCA alone, and the cross-validated AUC was .898 (95% CI: .792–.929). The probability of having capacity with a MoCA of 22 was 75% (95% CI: 63%–87%). The probability of having capacity with a MoCA of 15 was 24% (95% CI: 13%–35%).
Conclusions: By employing the MoCA as a screen for capacity, clinicians can utilize a common clinical tool to better inform their conversations about goals of care with patients and families. Validation of these findings in an independent dataset is warranted.
Disclosure: Noam Margalit has nothing to disclose. Dr. Alshaikh has nothing to disclose. Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Caremark. The institution of Dr. Mastrianni has received research support from Brain Research Foundation.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan
Related Articles
- No related articles found.